APUSApimeds Pharmaceuticals US, Inc.vs its industry peers
A metric-by-metric comparison of Apimeds Pharmaceuticals US, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APUSEsta | $4M#15 | — | 0.0x#1 | — | — | -331.7%#15 | — | -5.6%#1 | -11.2%#1 | — | -86.6%#1 | — |
| HYPD | $49M#1 | — | 0.5x#3 | 60.4x#5 | 1318.8%#1 | 9.0%#8 | -5743.5%#5 | -44.5%#3 | -46.8%#2 | — | — | — |
| SKYE | $47M#2 | — | — | — | — | -110.5%#13 | — | — | — | — | — | — |
| ATNM | $47M#3 | 4.3x#2 | 1.5x#10 | 520.5x#6 | — | 11.4%#7 | -40274.4%#6 | -111.8%#10 | — | — | — | — |
| CTOR | $47M#4 | — | 1.2x#8 | — | — | -17.1%#10 | — | -61.3%#6 | — | — | — | — |
| XLO | $46M#5 | — | 0.6x#6 | 1.1x#1 | 589.9%#2 | 39.8%#4 | -95.9%#2 | -48.5%#4 | — | — | — | — |
| AZTR | $46M#6 | 37.7x#4 | 6.2x#13 | — | -100.0%#6 | -22.2%#11 | — | -149.4%#11 | — | — | — | — |
| BMEA | $45M#7 | — | 3.7x#11 | — | — | 55.4%#2 | — | -509.2%#13 | — | — | — | — |
| ELTX | $44M#8 | — | 5.6x#12 | 19.3x#4 | -91.9%#5 | 23.8%#6 | -1639.0%#4 | -498.6%#12 | — | — | — | — |
| DWTX | $42M#9 | 0.7x#1 | 0.6x#5 | — | — | -177.4%#14 | — | -50.1%#5 | — | — | — | — |
| SCYX | $37M#10 | 13.4x#3 | 0.6x#4 | 1.8x#2 | 449.9%#3 | 59.6%#1 | -78.0%#1 | -12.9%#2 | — | 7#1 | — | — |
| VERU | $37M#11 | — | 1.3x#9 | 2.2x#3 | 3.6%#4 | 39.9%#3 | -146.6%#3 | -80.1%#7 | -399.3%#3 | — | — | 0.0%#1 |
| ALDX | $32M#12 | — | 0.8x#7 | — | — | 39.4%#5 | — | -89.3%#8 | — | — | — | — |
| ACET | $32M#13 | — | 0.3x#2 | — | — | 0.3%#9 | — | -97.2%#9 | — | — | — | — |
| RNAZ | $30M#14 | — | — | — | — | -106.9%#12 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice